March 2023

ENDOCRINOLOGY

EXPERT GUIDANCE ON OFF-LABEL USE OF HCL THERAPY IN PREGNANCIES COMPLICATED BY DIABETES

Featuring: Emily D. Szmuilowicz, MD​
In this research published May 2023 in Diabetes Technology & Therapeutics, Emily D. Szmuilowicz, MD, associate professor of Endocrinology at Northwestern Medicine, and colleagues provide expert guidance on the off-label use of hybrid closed-loop (HCL) therapy in pregnancies complicated by diabetes. Dr. Szmuilowicz draws on clinical experience and case reports to provide insights on candidate selection, counseling pregnant patients, and managing commercially available systems off-label in an assisted HCL approach.

This abstract was originally published on Diabetes Technology & Therapeutics in March 2023. ​
Emily D. Szmuilowicz, MD, associate professor of Medicine in the Division of Endocrinology at Northwestern Medicine. Program Director, Endocrinology Fellowship, Northwestern University Feinberg School of Medicine. Peer Coach, Department of Medicine, Northwestern University Feinberg School of Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like